An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of ERK1/2 also abolished expression of NOXA, consistent with observations that NOXA mRNA expression is promoted by ERK1/2 signalling39,40.”
From Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors (2019) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112 · cited 3×
“number of transcription factors including p53, Hif-1a and Myc have been implicated in the regulation of Noxa expression (Oda et al., 2000; Kim et al., 2004; Nikiforov et al., 2007).”
BackgroundChen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185 · cited 9×
“On activation, BH3-only proteins promote cell death by opening the mitochondrial Bax/Bak channel, thereby initiating the apoptosome pathway to apoptosis (Adrain and Martin, 2006).”
BackgroundInfluentialStepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis
Kim, H., Tu, H.-C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J.-D., & Cheng, E. H.-Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.030 · Cited by 600 · cited 9×
“On activation, BH3-only proteins promote cell death by opening the mitochondrial Bax/Bak channel, thereby initiating the apoptosome pathway to apoptosis (Adrain and Martin, 2006).”
BackgroundInfluentialSchimmer, A. D., O'Brien, S., Kantarjian, H., Brandwein, J., Cheson, B. D., Minden, M. D., Yee, K., Ravandi, F., Giles, F., Schuh, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0999 · Cited by 192 · cited 1×
“Thus, combination therapy with platinum compounds and Noxa-like BH3 mimetics, such as Obatoclax (GX15-070; Zhai et al., 2006; Nguyen et al., 2007; Schimmer et al., 2008), which are capable of inhibiting Mcl-1, may improve the efficacy of platinum agents in the treatment of human cancers.”
BackgroundRecent advances in management of patients with platinum‐refractory testicular germ cell tumors
Kollmannsberger, C., Nichols, C., & Bokemeyer, C. (2006) · Cancer · doi:10.1002/cncr.21742 · Cited by 77 · cited 2×
“Oncogene Oncogene cancers are highly responsive to cisplatin treatment and this chemotherapeutic agent efficiently eradicates early stage testicular tumors (Kollmannsberger et al., 2006).”
Background
Research works printed but not linked: 39
- Adrain C, Martin SJ . (2006). Cell biology. Double knockout blow for caspases. Science 311: 785–786. · doi:10.1126/science.1124154
- Alves NL, Derks IA, Berk E, Spijker R, van Lier RA, Eldering E . (2006). The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 24: 703–716. · DOI · Paper page
- Amran D, Sancho P, Fernandez C, Esteban D, Ramos AM, de Blas E et al. (2005). Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation. Biochim Biophys Acta 1743: 269–279. · doi:10.1016/j.bbamcr.2004.10.009
- Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME . (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286: 1358–1362. · DOI · Paper page
- Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T et al. (2001). BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705–711. · DOI · Paper page
- Choi SS, Park IC, Yun JW, Sung YC, Hong SI, Shin HS . (1995). A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693–1698.
- Cosaert J, Quoix E . (2002). Platinum drugs in the treatment of non-small-cell lung cancer. Br J Cancer 87: 825–833. · DOI
- Dhomen N, Marais R . (2007). New insight into BRAF mutations in cancer. Curr Opin Genet Dev 17: 31–39. · DOI · Paper page
- Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari Jr AW et al. (2005). Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65: 6294–6304. · DOI · Paper page
- Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M et al. (1999). The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806–809. · DOI · Paper page
- Hao D, Ritter MA, Oliver T, Browman GP . (2006). Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Semin Radiat Oncol 16: 10–19. · DOI
- Kim GP, Erlichman C . (2007). Oxaliplatin in the treatment of colorectal cancer. Expert Opin Drug Metab Toxicol 3: 281–294. · DOI
- Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH . (2004). BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199: 113–124. · DOI · Paper page
- Kolch W . (2005). Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6: 827–837. · DOI · Paper page
- Labi V, Erlacher M, Kiessling S, Villunger A . (2006). BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 13: 1325–1338. · DOI · Paper page
- Lennon SV, Martin SJ, Cotter TG . (1991). Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24: 203–214. · DOI · Paper page
- Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ . (2003). Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 278: 18811–18816. · DOI · Paper page
- Martin SJ, Cotter TG . (1990). Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL-60 cells. Cell Tissue Kinet 23: 545–559.
- Martin SJ, Green DR . (1994). Apoptosis as a goal of cancer therapy. Curr Opin Oncol 6: 616–621. · DOI
- Muggia F . (2009). Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol 112: 275–281. · DOI · Paper page
- Nguyen M, Marcellus RC, Roulston A, Watson M, Serfass L, Murthy Madiraju SR et al. (2007). Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci USA 104: 19512–19517. · DOI · Paper page
- Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. (2003). Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17: 1475–1486. · DOI · Paper page
- Nikiforov MA, Riblett M, Tang WH, Gratchouck V, Zhuang D, Fernandez Y et al. (2007). Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc Natl Acad Sci USA 104: 19488–19493. · DOI · Paper page
- O'Reilly LA, Kruse EA, Puthalakath H, Kelly PN, Kaufmann T, Huang DC et al. (2009). MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation. J Immunol 183: 261–269. · DOI · Paper page
- Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E . (2008). Chemotherapy for recurrent cervical cancer. Cancer Treat Rev 34: 603–613. · DOI
- Petit T, Bearss DJ, Troyer DA, Munoz RM, Windle JJ . (2003). p53-independent response to cisplatin and oxaliplatin in MMTV-ras mouse salivary tumors. Mol Cancer Ther 2: 165–171.
- Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V et al. (2005). Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 65: 6282–6293. · DOI · Paper page
- Schulze A, Nicke B, Warne PH, Tomlinson S, Downward J . (2004). The transcriptional response to Raf activation is almost completely dependent on mitogen-activated protein kinase kinase activity and shows a major autocrine component. Mol Biol Cell 15: 3450–3463. · DOI · Paper page
- Schweyer S, Soruri A, Meschter O, Heintze A, Zschunke F, Miosge N et al. (2004). Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br J Cancer 91: 589–598. · DOI
- Sheridan C, Brumatti G, Martin SJ . (2008). Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim. J Biol Chem 283: 22128–22135. · DOI · Paper page
- Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A et al. (2003). Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17: 2233–2238. · DOI · Paper page
- Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD et al. (1999). Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144: 281–292. · DOI · Paper page
- Taylor RC, Cullen SP, Martin SJ . (2008). Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231–241. · DOI · Paper page
- von Kriegsheim A, Baiocchi D, Birtwistle M, Sumpton D, Bienvenut W, Morrice N et al. (2009). Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol 11: 1458–1464. · DOI · Paper page
- Wang X, Martindale JL, Holbrook NJ . (2000). Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435–39443. · DOI · Paper page
- Willis SN, Adams JM . (2005). Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17: 617–625. · DOI · Paper page
- Wolf D, Rotter V . (1985). Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82: 790–794. · DOI · Paper page
- Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331. · DOI · Paper page
- Zhai D, Jin C, Satterthwait AC, Reed JC . (2006). Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins. Cell Death Differ 13: 1419–1421. · DOI · Paper page
Cited by
Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis
Hong, B.-Y., Sobue, T., Choquette, L., Dupuy, A. K., Thompson, A., Burleson, J. A., Salner, A. L., Schauer, P. K., Joshi, P., Fox, E., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0679-5 · Cited by 267
Sale, M. J., Minihane, E., Monks, N. R., Gilley, R., Richards, F. M., Schifferli, K. P., Andersen, C. L., Davies, E. J., Vicente, M. A., Ozono, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12409-w · Cited by 80
Sale, M. J., & Cook, S. J. (2013) · Biochemical Journal · doi:10.1042/bj20121212 · Cited by 58
Metadata
- Authors
- Sheridan, C., Brumatti, G., Elgendy, M., Brunet, M., & Martin, S. J.
- Venue
- Oncogene
- Published
- 2010-08-30
- Volume
- 29
- Issue
- 49
- Pages
- 6428-6441
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 71
- References
- 10
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs. https://app.cochat.ai/papers/10.1038/onc.2010.380
- The paper
- Sheridan, C., Brumatti, G., Elgendy, M., Brunet, M., & Martin, S. J. (2010). An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs. Oncogene. https://doi.org/10.1038/onc.2010.380
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.